Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Cegedim    CGM   FR0000053506

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

Cegedim : plans to respond positively to any acquisition offer for its Cegelease business

share with twitter share with LinkedIn share with facebook
share via e-mail
07/13/2017 | 08:01pm CEST

Press Release

Financial information
IFRS - Regulated information

Cegedim plans to respond positively to any acquisition offer for its Cegelease business

  • A selling agent has been hired
  • The Group has no other divestments planned
Disclaimer: This press release is available in French and in English. In the event of any difference between the two versions, the original French version takes precedence. This press release may contain inside information. It was sent to Cegedim's authorized distributor, under embargo, on July 13, no earlier than 5:45 pm Paris time.
The term "business model transformation" is defined in the glossary.

Boulogne-Billancourt, France, July 13, 2017 after the market close

Cegedim, an innovative technology and services company, has decided to sell its Cegelease business as part of its business model transformation strategy.

Since 2001, Cegelease, a wholly owned subsidiary of Cegedim, has been offering leasing contracts chiefly to pharmacies and healthcare professionals in France. The company has evolved from a reseller of products developed exclusively by the Group into a broker offering multi-solution financing contracts to a wide variety of clients. Today, Cegedim accounts for a minority of Cegelease's revenues. Eurofarmat, a wholly owned subsidiary of Cegedim Logiciels Médicaux, now specializes in selling used equipment and also develops and maintains the software used by Cegelease.

As part of the business model transformation plan that the Group initiated in fall 2015, Cegedim has decided to divest ifs Cegelease and Eurofarmat subsidiaries. These subsidiaries operate principally in the financial domain, are highly valued, and require additional resources to continue pursuing and accelerating their development for the benefit of their clients and employees.

The two businesses have 24 employees in France. In 2016 they contributed €5.4 million to Group consolidated EBITDA. The subsidiaries' standalone EBITDA amounted to €18.1 million in 2016.

If the Group receives satisfactory offers and is able to obtain the necessary approvals, it plans to close the deal in the second half of 2017. The Group in no way guarantees that a deal will be carried out.

A successful sale would give the Group a portfolio of businesses that fit well together and generate strong synergies. Cegedim is not planning any further divestments.

Cegedim reiterates that the Group was in compliance with its "Covenant" debt ratios as of June 30, 2017. A successful sale would improve those ratios significantly.

Assisting Cegedim on this transaction are the consulting firm of Ohana & Co and the law firm of Freshfields Bruckhaus Deringer.

Immediately after issuing this press release, the Group's quiet period will resume until its Q2 2017 revenue announcement on July 27.

Activities not allocated: This division encompasses the activities the Group performs as the parent company of a listed entity, as well as the support it provides to the three operating divisions.

BPO (Business Process Outsourcing): BPO is the contracting of non-core business activities and functions to a third-party provider. Cegedim provides BPO services for human resources, Revenue Cycle Management in the US and management services for insurance companies, provident institutions and mutual insurers.

Business model transformation: Cegedim decided in fall 2015 to switch all of its offerings over to SaaS format, to develop a complete BPO offering, and to materially increase its R&D efforts. This is reflected in the Group's revamped business model. The change has altered the Group's revenue recognition and negatively affected short-term profitability

EPS: Earnings Per Share is a specific financial indicator defined by the Group as the net profit (loss) for the period divided by the weighted average of the number of shares in circulation.

Operating expenses: Operating expenses is defined as purchases used, external expenses and payroll costs.

Revenue at constant exchange rate: When changes in revenue at constant exchange rate are referred to, it means that the impact of exchange rate fluctuations has been excluded. The term "at constant exchange rate" covers the fluctuation resulting from applying the exchange rates for the preceding period to the current fiscal year, all other factors remaining equal.

Revenue on a like-for-like basis: The effect of changes in scope is corrected by restating the sales for the previous period as follows:

  • by removing the portion of sales originating in the entity or the rights acquired for a period identical to the period during which they were held to the current period;
  • similarly, when an entity is transferred, the sales for the portion in question in the previous period are eliminated.
Life-for-like data (L-f-l): At constant scope and exchange rates.

Internal growth: Internal growth covers growth resulting from the development of an existing contract, particularly due to an increase in rates and/or the volumes distributed or processed, new contracts, acquisitions of assets allocated to a contract or a specific project.
  External growth: External growth covers acquisitions during the current fiscal year, as well as those which have had a partial impact on the previous fiscal year, net of sales of entities and/or assets.

EBIT: Earnings Before Interest and Taxes. EBIT corresponds to net revenue minus operating expenses (such as salaries, social charges, materials, energy, research, services, external services, advertising, etc.). It is the operating income for the Cegedim Group.

EBIT before special items: This is EBIT restated to take account of non-current items, such as losses on tangible and intangible assets, restructuring, etc. It corresponds to the operating income from recurring operations for the Cegedim Group.

EBITDA: Earnings before interest, taxes, depreciation and amortization. EBITDA is the term used when amortization or depreciation and revaluations are not taken into account. "D" stands for depreciation of tangible assets (such as buildings, machines or vehicles), while "A" stands for amortization of intangible assets (such as patents, licenses and goodwill). EBITDA is restated to take account of non-current items, such as losses on tangible and intangible assets, restructuring, etc. It corresponds to the gross operating earnings from recurring operations for the Cegedim Group.

Adjusted EBITDA :  Consolidated EBITDA adjusted, for 2016, for the €4.0m of negative impact from impairment of receivables in the Healthcare Professional division

Net Financial Debt: This represents the Company's net debt (non-current and current financial debt, bank loans, debt restated at amortized cost and interest on loans) net of cash and cash equivalents and excluding revaluation of debt derivatives.

Free cash flow: Free cash flow is cash generated, net of the cash part of the following items: (i) changes in working capital requirements, (ii) transactions on equity (changes in capital, dividends paid and received), (iii) capital expenditure net of transfers, (iv) net financial interest paid and (v) taxes paid.

EBIT margin: EBIT margin is defined as the ratio of EBIT/revenue.

EBIT margin before special items: EBIT margin before special items is defined as the ratio of EBIT before special items/revenue.

Net cash: Net cash is defined as cash and cash equivalent minus overdraft.



About Cegedim:

Founded in 1969, Cegedim is an innovative technology and services company in the field of digital data flow management for healthcare ecosystems and B2B, and a business software publisher for healthcare and insurance professionals. Cegedim employs more than 4,000 people in 11 countries and generated revenue of €441 million in 2016. Cegedim SA is listed in Paris (EURONEXT: CGM).
To learn more, please visit: www.cegedim.com
And follow Cegedim on Twitter: @CegedimGroup


Aude Balleydier
Media Relations
and Communications Manager
Tel.: +33 (0)1 49 09 68 81

Jan Eryk Umiastowski
Chief Investment Officer
and head of Investor Relations
Tel.: +33 (0)1 49 09 33 36

Anne Pezet
PRPA Agency
Media Relations


Tel.: +33 (0)1 46 99 69 69


Follow Cegedim:

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Cegedim SA via Globenewswire

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on CEGEDIM
07/13 CEGEDIM : plans to respond positively to any acquisition offer for its Cegelease..
07/11 CEGEDIM : and Visiomed Group ratchet up their collaboration
07/11 CEGEDIM : and Visiomed Group ratchet up their collaboration
07/06 CEGEDIM : Bouygues Telecom opts for Cegedim’s KISS solution to achieve its..
07/05 CEGEDIM : Summary of the liquidity contract as of June 30, 2017
06/07 CEGEDIM : Insurance Solutions and B2V launch the "B2V Prévention” online p..
05/23 CEGEDIM : Restalliance picks Cegedim SRH to revamp its HRIS
05/11 CEGEDIM : SRH partners with FIRALP to revamp its HRIS
05/04 CEGEDIM : MSD France chooses Cegedim SRH’s TPO transparency solution
04/28 CEGEDIM : Presentation of Q1 2017 Revenues
More news
Financials (€)
Sales 2017 468 M
EBIT 2017 33,9 M
Net income 2017 20,6 M
Debt 2017 227 M
Yield 2017 1,41%
P/E ratio 2017 20,10
P/E ratio 2018 14,24
EV / Sales 2017 1,44x
EV / Sales 2018 1,34x
Capitalization 447 M
Duration : Period :
Cegedim Technical Analysis Chart | CGM | FR0000053506 | 4-Traders
Technical analysis trends CEGEDIM
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 3
Average target price 26,3 €
Spread / Average Target -17%
EPS Revisions
Jean-Claude Labrune Chairman & Chief Executive Officer
Jan-Eryk Umiastowski CFO, Chief Investment Officer & IR Contact
Pierre Marucchi Director & Deputy Chief Executive Officer
Laurent Labrune Director
Aude Labrune-Marysse Director
Sector and Competitors
1st jan.Capitalization (M$)
SAP7.33%127 304
INTUIT17.65%34 609
SERVICENOW INC45.53%18 379